Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

This study has been terminated.
(Study has been suspended due to clinical hold.)
Information provided by (Responsible Party):
FORUM Pharmaceuticals Inc Identifier:
First received: October 21, 2013
Last updated: May 2, 2016
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)